VPT
vs
S
S&P TSX Composite Index (Canada)
VPT
Over the past 12 months, VPT has significantly outperformed S&P TSX Composite Index (Canada), delivering a return of +60% compared to the S&P TSX Composite Index (Canada)'s +34% growth.
Stocks Performance
VPT vs S&P TSX Composite Index (Canada)
Performance Gap
VPT vs S&P TSX Composite Index (Canada)
Performance By Year
VPT vs S&P TSX Composite Index (Canada)
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
VentriPoint Diagnostics Ltd
Glance View
VentriPoint Diagnostics Ltd. is a medical device company, which engages in the development and commercialization of diagnostic tools that monitor patients with heart disease. The company is headquartered in North York, Ontario. The company went IPO on 2005-11-09. The firm offers Ventripoint Medical System (VMS) equipment. The firm's VMS+ is a diagnostic aid, which is developed to provide a point-of care solution to communicate the heart's structure and function without the need for magnetic resonance imaging (MRI). Its VMS+ is designed to create a three-dimensional (3D) model of the heart from a two-dimensional (2D) echocardiogram and allows cardiac metrics on all four chambers of the heart within minutes. The firm enables VMS+ software to be installed on any personal workstation. The Company’s Knowledge Based Reconstruction (KBR) enables to construct a 3D model of the heart and calculates volumes and ejection fractions for all chambers. The firm has not generated any revenues.
